Clonell™ Launches the Ultimate Regenerative Medicine Platform
Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world’s first ‘Patient-Specific Embryonic...